Boehringer latest to axe Alzheimer’s drug
BERLIN: Boehringer Ingelheim has axed development of a potential therapy for Alzheimer’s after it failed…
BERLIN: Boehringer Ingelheim has axed development of a potential therapy for Alzheimer’s after it failed…